125 related articles for article (PubMed ID: 12369969)
1. N-oxides as hypoxia selective cytotoxins.
Cerecetto H; González M
Mini Rev Med Chem; 2001 Sep; 1(3):219-31. PubMed ID: 12369969
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as potential hypoxic cytotoxins and DNA-binders.
Cerecetto H; González M; Risso M; Seoane G; López de Ceráin A; Ezpeleta O; Monge A; Suescun L; Mombrú A; Bruno AM
Arch Pharm (Weinheim); 2000 Nov; 333(11):387-93. PubMed ID: 11129981
[TBL] [Abstract][Full Text] [Related]
3. Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins.
Hay MP; Hicks KO; Pchalek K; Lee HH; Blaser A; Pruijn FB; Anderson RF; Shinde SS; Wilson WR; Denny WA
J Med Chem; 2008 Nov; 51(21):6853-65. PubMed ID: 18847185
[TBL] [Abstract][Full Text] [Related]
4. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
[TBL] [Abstract][Full Text] [Related]
5. Phenazine 5,10-dioxide derivatives as hypoxic selective cytotoxins: Part II. Structure-activity relationship studies.
Cerecetto H; González M; Lavaggi ML; Aravena MA; Rigol C; Olea-Azar C; Azqueta A; de Cerain AL; Monge A; Bruno AM
Med Chem; 2006 Sep; 2(5):511-21. PubMed ID: 17017991
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in bioreductive drug targeting.
Naylor MA; Thomson P
Mini Rev Med Chem; 2001 May; 1(1):17-29. PubMed ID: 12369988
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological activities of antiangiogenic hypoxic cytotoxin, triazine-N-oxide derivatives.
Nagasawa H; Yamashita M; Mikamo N; Shimamura M; Oka S; Uto Y; Hori H
Comp Biochem Physiol A Mol Integr Physiol; 2002 May; 132(1):33-40. PubMed ID: 12062188
[TBL] [Abstract][Full Text] [Related]
8. Phenazine 5,10-dioxide derivatives as hypoxic selective cytotoxins.
Cerecetto H; González M; Lavaggi ML; Azqueta A; López de Cerain A; Monge A
J Med Chem; 2005 Jan; 48(1):21-3. PubMed ID: 15633996
[TBL] [Abstract][Full Text] [Related]
9. Fine-tuning the amphiphilicity: a crucial parameter in the design of potent alpha-phenyl-N-tert-butylnitrone analogues.
Durand G; Poeggeler B; Böker J; Raynal S; Polidori A; Pappolla MA; Hardeland R; Pucci B
J Med Chem; 2007 Aug; 50(17):3976-9. PubMed ID: 17649989
[TBL] [Abstract][Full Text] [Related]
10. Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity.
Lee HH; Wilson WR; Denny WA
Anticancer Drug Des; 1999 Dec; 14(6):487-97. PubMed ID: 10834270
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of new symmetric curcumin derivatives.
Sribalan R; Kirubavathi M; Banuppriya G; Padmini V
Bioorg Med Chem Lett; 2015 Oct; 25(19):4282-6. PubMed ID: 26264500
[TBL] [Abstract][Full Text] [Related]
12. Bis-tropolonato derivatives of cobalt(III) complexes of bidentate aliphatic nitrogen mustards as potential hypoxia-selective cytotoxins.
Ware DC; Palmer HR; Brothers PJ; Rickard CE; Wilson WR; Denny WA
J Inorg Biochem; 1997 Nov; 68(3):215-24. PubMed ID: 9352654
[TBL] [Abstract][Full Text] [Related]
13. Structural modifications on the phenazine N,N'-dioxide-scaffold looking for new selective hypoxic cytotoxins.
Lavaggi ML; Nieves M; Cabrera M; Olea-Azar C; López de Ceráin A; Monge A; Cerecetto H; González M
Eur J Med Chem; 2010 Nov; 45(11):5362-9. PubMed ID: 20846761
[TBL] [Abstract][Full Text] [Related]
14. Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent.
Patterson LH
Cancer Metastasis Rev; 1993 Jun; 12(2):119-34. PubMed ID: 8375016
[TBL] [Abstract][Full Text] [Related]
15. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D
J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
[TBL] [Abstract][Full Text] [Related]
16. Bioreducible mustards: a paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs).
Denny WA; Wilson WR
Cancer Metastasis Rev; 1993 Jun; 12(2):135-51. PubMed ID: 8375017
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and electrochemical and biological studies of novel coumarin-chalcone hybrid compounds.
Pérez-Cruz F; Vazquez-Rodriguez S; Matos MJ; Herrera-Morales A; Villamena FA; Das A; Gopalakrishnan B; Olea-Azar C; Santana L; Uriarte E
J Med Chem; 2013 Aug; 56(15):6136-45. PubMed ID: 23859213
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.
Monge A; Palop JA; López de Ceráin A; Senador V; Martínez-Crespo FJ; Sainz Y; Narro S; García E; de Miguel C; González M
J Med Chem; 1995 May; 38(10):1786-92. PubMed ID: 7752202
[TBL] [Abstract][Full Text] [Related]
19. Design of chalcogen-containing norepinephrines: efficient GPx mimics and strong cytotoxic agents against HeLa cells.
Marset A; Begines P; López Ó; Maya I; García-Aranda N; Schwartz S; Abasolo I; Fernández-Bolaños JG
Future Med Chem; 2016 Dec; 8(18):2185-2195. PubMed ID: 27845568
[TBL] [Abstract][Full Text] [Related]
20. N-hydroxybenzenecarboximidic acid derivatives: a new class of nitroxyl-generating prodrugs.
Lee MJ; Shoeman DW; Goon DJ; Nagasawa HT
Nitric Oxide; 2001 Jun; 5(3):278-87. PubMed ID: 11384201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
